ARTICLE | Clinical News
Abelcet liposomal amphotericin B regulatory update
February 28, 2000 8:00 AM UTC
Lebanon granted marketing approval for LIPO's Abelcet to treat invasive fungal infections in patients refractory to or intolerant of conventional amphotericin B. ...